Tag
Tag: Boehringer Ingelheim
Boehringer Ingelheim Acquires Cancer Vaccine Biotech in €325M Deal
Boehringer Ingelheim Acquires Oncolytic Virus Biotech Company
Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech
No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug
Qiagen Gets the Green Light to Roll Out its Diagnostic Test in Lung Cancer
Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech
Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner
German Pharma and Biotech Gang Up on NASH in an Exciting Collaboration
German Humira Biosimilar for Inflammatory Diseases Cleared for EMA Approval
More News! Big Money for a Danish CRO, a Bad Opinion for a Swiss Pharma
